ASX:RMD

ResMed Inc. · ASX · Healthcare · AUD · FY for 2025

Figures on this page computed 2026-11-08 12:25 UTC

Last close

n/aAUD

Market data

24.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed
- Computed from the filing for 2025
25.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
27.2%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2025
- Computed from the filing for 2025
32.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.14Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed

Price is the furthest below its sector's middle: 0.27 against 0.36 on the market's range.

Five bars, one line

lens 7 of 9

1.10x

1.27x

1.42x

0.77x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.10x
Its own average over 3 years, 4.68B.
Profit1.27x
Its own average over 3 years, 1.11B.
Free cash flow1.42x
Its own average over 3 years, 1.17B.
Debt0.77x
Its own average over 3 years, 1.11B.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 1.42 times.

Sales is 1.10 times its own 3-year average; Profit is 1.27 times its own 3-year average; Free cash flow is 1.42 times its own 3-year average; Debt is 0.77 times its own 3-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 3-year average1.10
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Profit against its own 3-year average1.27
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Free cash flow against its own 3-year average1.42
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Debt against its own 3-year average0.77
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
AUD